How power imbalances in the narratives, research, and publications around long covid can harm patients

Amali Lokugamage and colleagues argue that patients are still struggling to get their voices heard above doctors, a situation that risks “structural iatrogenesis”

Social media platforms have brought together thousands of people with long covid, allowing them to discuss, share, and compare their experiences of relapsing and remitting symptoms. [1] This phenomenon has disrupted and flattened traditional power structures, where doctors were always the experts and patients’ opinions were less valid. But power imbalances remain, especially in the creation of health knowledge, where prominent names in medicine seem to get easy access to the media—leaving less well resourced lay people who are affected by long covid feeling aggrieved and disempowered.

Several research papers describe abnormalities confirming pathophysiological damage ranging from abnormal blood tests to organ damage seen on MRI imaging or in postmortem findings. [2-4] These publications run counter to the tendency among many doctors to put long covid symptoms down to anxiety or to attribute other psychological labels, which then allows them to avoid investigating symptoms to look for organic pathology. [1] Organic disease processes are clearly at work. [5-8] This has been recognised by recent interim guidance from the US Centers for Disease Control on managing people with long covid. [9]

We don’t deny that all symptoms will have a psychological impact on the individual, and we would not wish psychological impacts to be stigmatised or ignored, but organic illness must be investigated and should be excluded only after appropriate investigation. [1] People with long covid describe feeling “gaslighted” because the opinions of a few have tended to dominate the evolution of treatment, investigation, and a growing knowledge base. [1]

We believe that this is a form of “structural iatrogenesis,” where patients are harmed by power imbalances in the bureaucratic and cultural systems within medicine. [10] Narratives on social media reveal that research produced by patients themselves has encountered more obstacles to publication, with journals claiming that it comes from the “wrong sort of expert.” [11-13]

Twitter and other social media are correcting this imbalance, although the results aren’t always pleasant. Behind the Twitter “spats” are thousands of individual patients with long covid who believe that advocating for graded exercise therapy rather than pacing to manage fatigue in long covid may lead to management regimens that make symptoms worse. [14]

Knowledge production in this new condition of long covid must therefore involve and engage patients and the public, not only to ensure co-production of knowledge, but also to avoid top-down hierarchical service provision, which may make logical sense to people who have never experienced the condition, but will be totally inappropriate to those affected by long covid.

Ultimately, toppling endemic power imbalances in medicine requires the input of people who have experienced the cognitive dissonance of confronting personal and healthcare structural biases, so that those providing healthcare fully comprehend the lived realities of the individuals they seek to serve. This is work that cannot be avoided.

Carolyn Chew-Graham is a GP in Manchester, and professor of general practice research, School of Medicine, Keele University

Amali Lokugamage is a consultant obstetrician and gynaecologist, and honorary associate professor, University College London and Whittington Hospital NHS Trust, London

Frances Simpson, founding member of Long Covid Kids and LongCovidSOS and lecturer in psychology, Coventry University

Follow the authors on Twitter: @CizCG; @Docamali; @FrancesorFran

Competing interests: AL and FS both declare the fact they have long covid. CC-G declares no competing interests.

Provenance and peer review: Commissioned; not externally peer reviewed.

References:

  1. Lokugamage AU, Bowen MA, Blair J. Long covid: doctors must assess and investigate patients properly. BMJ 2020;371:m4583. doi:10.1136/bmj.m4583. PubMed
  2. Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021;594:25964. doi:10.1038/s41586-021-03553-9. PubMed
  3. Dennis A, Wamil M, Alberts J, et al; COVERSCAN study investigators. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open 2021;11:e048391. doi:10.1136/bmjopen-2020-048391. PubMed
  4. Misra S, Kolappa K, Prasad M, et al. Frequency of neurological manifestations in COVID-19: a systematic review and metasynthesis of 350 studies. medRxiv [preprint] 2021. doi:10.1101/2021.04.20.21255780.
  5. Basso C, Leone O, Rizzo S, et al. Pathologic features of COVID-19 associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J 2020;41:382735. https://doi.org/10.1093/eurheartj/ehaa664.
  6. Santoriello D, Khairallah P, Bomback AS, et al. Postmortem Kidney Pathology Findings in Patients with COVID-19. J Am Soc Nephrol 2020;31:215867. PubMed doi:10.1681/ASN.2020050744.
  7. Mukerji SS, Solomon IH. What can we learn from brain autopsies in COVID-19? Neurosci Lett 2021;742:135528. doi:10.1016/j.neulet.2020.135528. PubMed
  8. Rendeiro AF, Casano J, Vorkas CK, et al. Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression. Life Sci Alliance 2020;4:e202000955. doi:10.26508/lsa.202000955.
  9. Centers for Disease Control and Prevention. Evaluating and caring for patients with post-covid conditions: interim guidance. Updated 14 Jun 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-index.html?fbclid=IwAR3m3fU83QGl8Ztgpjh3shhHNMwJ2dmW651xPWF_CHGon5iOh-459kIKsV8.
  10. Stonington S, Coffa D. Structural iatrogenesis—a 43-year-old man with “opioid misuse”. N Engl J Med 2019;380:7014. doi:10.1056/NEJMp1811473. PubMed
  11. Nurek M, Rayner C, Freyer A, et al. Recommendations for the recognition, diagnosis, and management of patients with post covid-19 condition (“long covid”): a Delphi study. Lancet [preprint] 2021 Apr 8. https://ssrn.com/abstract=3822279. doi:10.2139/ssrn.3822279.
  12. Davis HE, Assaf GS, McCorkell L, et al. Characterizing long covid in an international cohort: 7 months of symptoms and their impact. medRxiv 2020. doi:10.1101/2020.12.24.20248802.
  13. Buonsenso D, Espuny Pujol F, Munblit D, Mcfarland S, Simpson F. Clinical characteristics, activity levels and mental health problems in children with long covid: a survey of 510 children. Preprints [preprint] 2021:2021030271. doi:10.20944/preprints202103.0271.v1.
  14. World Physiotherapy. World Physiotherapy response to covid-19, briefing paper 9. Safe rehabilitation approaches for people living with long covid: physical activity and exercise. Jun 2021. https://world.physio/sites/default/files/2021-06/Briefing-Paper-9-Long-Covid-FINAL.pdf.